KBI Global Investors’s Pfizer PFE Stock Holding History

KBI Global Investors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$71.4M	Buy	+2,138,412	New	+$68.2M	1.91%	10

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

KBI Global Investors's PFE Position: Q2 2016 in Review

KBI Global Investors opened a new position in Pfizer (PFE) in Q2 2016: 2,138,412 shares worth $71.4M. The stake represents 1.91% of the portfolio and ranks #10 among its holdings.

1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

KBI Global Investors held 2,138,412 shares of Pfizer worth $71.4M as of Q2 2016.
Pfizer was a new KBI Global Investors position in Q2 2016.
Pfizer made up 1.91% of KBI Global Investors's portfolio in Q2 2016, its #10 holding.
1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on KBI Global Investors's 13F filing for Q2 2016, filed 3 Aug 2016.